date,title,source
Oct-26-18,"Market Trends Toward New Normal in Ascendis Pharma A/S, Diodes, Laureate Education, Randgold Resources, Fastenal, and LTC Properties  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Nov-08-18,Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon Endocrinology Rare Disease Therapies in China,GlobeNewswire
Nov-28-18,Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-28-18,Ascendis Pharma A/S Announces Positive Preliminary Phase 1 Data for TransCon CNP,GlobeNewswire
